| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.08▲ | 5.10▼ | 5.08▼ | 5.07▲ | 5.20▼ |
| MA10 | 5.08▲ | 5.09▼ | 5.13▼ | 5.34▼ | 5.39▼ |
| MA20 | 5.09▼ | 5.13▼ | 5.13▼ | 5.27▼ | 5.80▼ |
| MA50 | 5.12▼ | 5.07▲ | 5.20▼ | 5.49▼ | 4.97▲ |
| MA100 | 5.13▼ | 5.25▼ | 5.37▼ | 5.79▼ | 3.82▲ |
| MA200 | 5.06▲ | 5.34▼ | 5.34▼ | 5.30▼ | 3.98▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.009▼ | 0.000▲ | -0.022▼ | -0.141▼ |
| RSI | 46.965▼ | 45.389▼ | 44.522▼ | 43.129▼ | 46.975▼ |
| STOCH | 57.222 | 26.775 | 20.085 | 20.660 | 22.542 |
| WILL %R | -50.000 | -84.615▼ | -80.488▼ | -77.953▼ | -87.638▼ |
| CCI | -19.518 | -74.403 | -87.218 | -76.619 | -99.926 |
| ▼ MA | $IVA MA(20) Crossed Below MA(200) | Set Alert |
|
Thursday, May 21, 2026 01:11 PM
Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic ...
|
|
Thursday, May 21, 2026 09:59 AM
Looking for the most shorted stocks?
|
|
Monday, March 23, 2026 10:00 AM
Daix (France), New York (United States), March 23, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/05/26 | 5.21 | 5.28 | 5.05 | 5.07 | 184,965 |
| 21/05/26 | 5.11 | 5.25 | 5.04 | 5.21 | 119,431 |
| 20/05/26 | 4.91 | 5.19 | 4.91 | 5.14 | 159,814 |
| 19/05/26 | 5.00 | 5.02 | 4.79 | 4.91 | 273,587 |
| 18/05/26 | 5.37 | 5.37 | 4.96 | 5.02 | 238,000 |
| 15/05/26 | 5.66 | 5.66 | 5.37 | 5.44 | 284,477 |
| 14/05/26 | 5.66 | 5.66 | 5.43 | 5.55 | 137,208 |
| 13/05/26 | 5.74 | 5.74 | 5.52 | 5.54 | 106,246 |
| 12/05/26 | 5.80 | 5.85 | 5.695 | 5.75 | 89,134 |
| 11/05/26 | 5.62 | 6.06 | 5.62 | 5.80 | 1,100,362 |
|
|
||||
|
|
||||
|
|